Keyword: American Heart Association
The Medicines Company, fresh from its turn at the AHA this weekend, has seen its shares jump on growing rumors that Novartis wants to acquire it.
The top-line readout appears to justify the risk the partners took when they advanced the drug despite missing the primary endpoint in phase 2.
We tend to think of heart disease and heart disorders to be, in the main, things that affect men more than women, but this is not true.
Janssen is planning its first completely virtual clinical trial, using personal smartphones and wearable devices with no in-person site visits.
HDL unveiled data showing its treatment reduced reduced coronary artery damage in patients with a genetic disorder that causes high cholesterol.
The medtech giant said the data suggests adding the test to physicals of healthy middle-aged adults to help ward off the onset of heart disease.
Eko's AI could allow a broader number of physicians to digitally screen patients for heart murmurs without needing a trained cardiologist.
HeartHero, a startup developing a portable AED, will license VivaQuant’s ECG technology for the detection of potentially fatal heart arrhythmias.
Stanford scientists are using CRISPR to model individual patients’ hearts and identify which gene variants raise their risk of sudden cardiac death.